Beyond cholesterol metabolism, the reduced BA levels in humans might impair FXR and TGR5 signaling, thereby enhancing NF-κB–mediated inflammation in macrophages and vascular cells, exacerbating cholesterol accumulation and endothelial dysfunction. Here, GPBAR1 is linked to endothelial dysfunction.